TY - JOUR
T1 - Evolving Trends and Health Disparities in Peripheral Artery Disease in the United States (1999-2024)
AU - Muhammad, Abdullah Naveed
AU - Neppala, Sivaram
AU - Rehan, Muhammad Omer
AU - Ali, Ahila
AU - Naveed, Hamza
AU - Iqbal, Rabia
AU - Azeem, Bazil
AU - Chikatimalla, Rahul
AU - Kapaganti, Sowjanya
AU - Ahmed, Mushood
AU - Shuja, Hamza
AU - Chigurupati, Himaja Dutt
AU - Sattar, Yasir
AU - Rana, Jamal S.
N1 - Publisher Copyright:
© 2025 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2025
Y1 - 2025
N2 - Peripheral artery disease (PAD) is a common progressive atherosclerotic condition that significantly affects morbidity and mortality in the United States. However, data on PAD-related mortality trends are limited. This study investigates contemporary mortality trends across various sociodemographic and regional factor groups. CDC-WONDER (1999-2024) data were analyzed to assess PAD-related mortality in patients aged ≥25. Using the Joinpoint regression analysis, we calculated age-adjusted mortality rates (AAMR) per 100,000 patients and average annual percentage changes (AAPCs) to analyze the mortality trends. PAD accounted for 793,773 deaths between 1999 and 2024. The AAMRs decreased from 18.0 in 1999 to 13.0 in 2024 (AAPC: -1.37). The most significant decline occurred from 1999 to 2010 [annual percent change (APC): -3.46] and 2021 to 2024 (APC: -3.96). However, there was a concerning rise from 2018 to 2021 (APC: 5.42), possibly due to the pandemic, all with P < 0.01. Disparities are evident, as men have higher AAMRs than women (16.8 vs. 11.4), and non-Hispanic (NH) Black individuals are at the highest risk (AAMR: 28.8), followed by NH Whites (AAMR: 13.6). Regionally, West Virginia reports the highest AAMR at 18.5, in contrast to Utah's lowest rate of 7.1. Moreover, rural areas exhibited higher AAMRs than urban settings (15.2 vs. 13.2). In the United States, mortality trends among patients with PAD have significantly declined; however, from 2018 to 2021, these trends experienced a reversal, likely influenced by the COVID-19 pandemic. Enhancing healthcare access and implementing targeted interventions can mitigate these disparities and improve patient outcomes.
AB - Peripheral artery disease (PAD) is a common progressive atherosclerotic condition that significantly affects morbidity and mortality in the United States. However, data on PAD-related mortality trends are limited. This study investigates contemporary mortality trends across various sociodemographic and regional factor groups. CDC-WONDER (1999-2024) data were analyzed to assess PAD-related mortality in patients aged ≥25. Using the Joinpoint regression analysis, we calculated age-adjusted mortality rates (AAMR) per 100,000 patients and average annual percentage changes (AAPCs) to analyze the mortality trends. PAD accounted for 793,773 deaths between 1999 and 2024. The AAMRs decreased from 18.0 in 1999 to 13.0 in 2024 (AAPC: -1.37). The most significant decline occurred from 1999 to 2010 [annual percent change (APC): -3.46] and 2021 to 2024 (APC: -3.96). However, there was a concerning rise from 2018 to 2021 (APC: 5.42), possibly due to the pandemic, all with P < 0.01. Disparities are evident, as men have higher AAMRs than women (16.8 vs. 11.4), and non-Hispanic (NH) Black individuals are at the highest risk (AAMR: 28.8), followed by NH Whites (AAMR: 13.6). Regionally, West Virginia reports the highest AAMR at 18.5, in contrast to Utah's lowest rate of 7.1. Moreover, rural areas exhibited higher AAMRs than urban settings (15.2 vs. 13.2). In the United States, mortality trends among patients with PAD have significantly declined; however, from 2018 to 2021, these trends experienced a reversal, likely influenced by the COVID-19 pandemic. Enhancing healthcare access and implementing targeted interventions can mitigate these disparities and improve patient outcomes.
KW - age-adjusted mortality rates
KW - ethnicity
KW - geographic regions
KW - peripheral artery disease
KW - race
KW - sex
UR - https://www.scopus.com/pages/publications/105010587592
UR - https://www.scopus.com/pages/publications/105010587592#tab=citedBy
U2 - 10.1097/CRD.0000000000000992
DO - 10.1097/CRD.0000000000000992
M3 - Review article
C2 - 40622147
AN - SCOPUS:105010587592
SN - 1061-5377
JO - Cardiology in review
JF - Cardiology in review
M1 - 0992
ER -